Inpatient Smoking Cessation Pilot Program

Johns Hopkins University

Status and phase: Withdrawn; Early Phase 1

Conditions: Tobacco Use Cessation

Treatments: Other: Maryland Quitline; Drug: Nicotine lozenge; Drug: Nicotine gum; Other: John Hopkins Tobacco Treatment Clinic; Drug: Nicotine patch

Study type: Interventional

Funder types: Other

Identifiers

NCT05060965

IRB00208192

Details and patient eligibility

About

The investigators are implementing a stepwise approach to cessation with a public health focus to improve health outcomes for the investigators' pediatric patients. The investigators are focusing on addressing caregiver smoking as a modifiable risk factor during time of child's hospitalization as a window of opportunity to provide counseling and education to families on secondhand and third hand smoke exposure as well as information on NRT products to heighten caregiver contemplation for quitting. One of the central goals of the investigators' project is to increase immediate access to Nicotine Replacement Therapy (NRT) resources for families during hospitalization which pediatric providers could potentially dose and prescribe to caregivers who are screened positive for smoking. Long-term cessation care is provided by referrals to both the MD Quitline and the John Hopkins Tobacco Treatment Clinic. Both are provided to allow participants options that the participants would find preferable from an insurance and provider perspective.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Caregivers of patients on an inpatient unit at Johns Hopkins Children's Center who self-identify as tobacco users and wish to initiate tobacco cessation

Exclusion criteria

• Pregnant or breast feeding maternal caregivers.

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Cessation intervention

Experimental group

Description:

All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care. Nicotine replacement therapy: Nicoderm patches, gum, lozenges * Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg) * Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg) * High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg) Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".

Treatment:

Drug: Nicotine gum

Drug: Nicotine lozenge

Other: John Hopkins Tobacco Treatment Clinic

Other: Maryland Quitline

Drug: Nicotine patch